Metraipolis › archive › dc_e22a23c600fc

Fostemsavir analog BMS-818251 has enhanced viral neutralization potency and similar escape mutation profile — Europe PMC PMID:40863730

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40863730
DOI
10.1128/aac.01910-24
License (as archived)
solo-consultazione
Archived
2026-11-10T07:57:30.022Z
SHA-256 of the archived text
3cd81dd22a144378fdb95de58cf36728384e60e28e582a8a51f95a2e00ec1015
Stable URL of this page
https://metraipolis.com/documento/dc_e22a23c600fc

How to cite

Fostemsavir analog BMS-818251 has enhanced viral neutralization potency and similar escape mutation profile — Europe PMC PMID:40863730 — Europe PMC (en), https://europepmc.org/article/MED/40863730 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e22a23c600fc (Metraipolis archive dc_e22a23c600fc, sha256 3cd81dd22a144378fdb95de58cf36728384e60e28e582a8a51f95a2e00ec1015)
BibTeX
@misc{dce22a23c600fc,
  title = {Fostemsavir analog BMS-818251 has enhanced viral neutralization potency and similar escape mutation profile — Europe PMC PMID:40863730},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40863730},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e22a23c600fc; sha256 3cd81dd22a144378fdb95de58cf36728384e60e28e582a8a51f95a2e00ec1015},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40863730. Agents can read the archived copy with the MCP tool read_document.